PRenatal and Obstetric Maternal Exposures and ISlet Autoantibodies in Early Life (PROMISE)

About the PROMISE Study

Are you an expectant parent with Type 1 diabetes? Learn about our study below.

Eligibility

• Baby’s mother or father has type 1 diabetes for at least 12 months, or a full sibling of the baby has type 1 diabetes
• Mother 8-24 weeks gestation with a singleton pregnancy also willing to participate
• Parents 18 years of age or older

Study Procedures

• Blood collected from mother and questionnaires filled out once per trimester and once after delivery
• Screen baby for genetic risk of type 1 diabetes, and have your child followed for measurement of islet autoimmunity, through 5-6 years of age
• Father is also asked to complete one visit during pregnancy